THE FREENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE ANNUAL REPORT AND AUDrrED FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2024 Charfty No 264136
ThE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE ANNUAL REPORT ANO FINANCIAL STATEMENTS YENR ENDED 31 DECEMBER 2024 The Trust was tstablished urwJ•r a trust deed in April 1972 in order to provide Telieflo pthnts al tho ¢enlre and to $uFwt th8 WO ofth c4ntre. Tho Trust 1$ 8 i¢giitsred thority. Pfesldent.. The Lord Mayor of Bristol Officor Chalr Genaral Secretary Trea8urer Mrs O Grogono Miss Fl Earltr Mrs CM Owen Mr S Blake MTS A Carlton Mr GJ Clements Mrs L Densham Mrs G Cr8a$g Dr G Crichton Mrs N Day Mrs O Grogono Mrs J Lothwood Mr S Mocylon Mr3 P Murphy Mrs CM Owen Mrs S Sims Mrs A Thomas Athisorn Bankers N8thMèI Westminsier Bank plc Bristol Cty Office Audittsrs Charlton Baker (Bristol) Limit8d 1st Flcrf)r 61 Macrae Road Ham Gen istol BS20 ODD Stock brokefs pha Pcrtfolio Management 1 rhe Square Templ8 Q[Y Brisiol Bristol Haematology aThY On9Y Centre Horfield Road 8ristol 0117 342 3432 T•Phone
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE ANNUAL REPORT AND FINANCIAL STATeMENTS YEIR ENCED 31 DECEMBER 2024 Tru8t•es' r•port The twstees present their reput 8Th1 lh8 8udled financial statements frjr lh8 yèar ènd8d 31 D8C8rnber 2024. The finanrAal statemenls have eTh Wep in accordan wilh the Statement of Recommended Prac1". Accountirrfj and Reportiro by Chantiès prèpating their a(Lounts in accofdance wrth the Fsn8ncial Reporting Standard applicable in the UK and Republic of Ireland IFRS1021 aryj Ihe Finanaal Reporting Stsrthrd applicat)le In the United Kingdom and Republic of Ir•PdtKI IFRS1021 and the Charrti8s A 2011 And UK Generalty AttÈpt8d Practi a$ it 8pplw 1 January 2015 Con8tltution and oblects The Trusf wa5 consts'tuted under the model deed lor FThJ$ of Hospita15. A revisgd constitution was adopted in Septemter 20Lb. The prinrip81 obied of the Tw5t as set out in the constitution is to offer reliel to patients and former patients and to suppcrt the wotk of the Centre. During th& y•ai. rna¥> obieth.vas ntinU¢d tts b¢ IlYJs ol fundrsislng and man8gemènt ol th• portfdio. &nabling financial sw)port to be gNen to lh8 Brstol Haw)atok¥Jy and Oncdogy Centre in respect of specific proiects. The trustees confirm Ih8t they have ref8rred to thg guKlaKe contained in thè Charity CommtS5ioners' g8n8r81 guid8Trc& on pubb'c b8n8fft vthen revwying th¢ Tnjsvs aims and Dblecives Bnd in plaming luture bjnding of the Centre. Strneture and orgonSzatlon rhe Tru3t 18 uninry)rpor8teJ and i8 8 regi4tered tharty. The trustees in offieR duiing the year and 8t the date of thi8 report set crtrt on page l. A main committee as set out In the constitutiors manages the Trust. Meetings are hehl quarterty and are atteTrJed by representstNes from the h05Prtal. Trustee5 a invited to join the committee by existing trustee5 or by comMendatIOnS from hospital staff. In addibon to I main cornmrtteè thara B an investmènt commrttè& whith has r6sponsrtJiltty for inS"ng th• Trust's TrsaNes. The investment ¢oMrn1tt is chaired by Mrs O Grogono. The lDwing tru3tee¥ also serve on the Mil$ee.. Mr GJ cfements, and Mrs CM Owen. Raview of activitia# and fviurn develowants DuriThJ thg year Ihe Trust hes continued to raise money to tenefft thtr pients (rf The Bit8tol Haematoloyy and Oncol(yJy Cent. The fundraising is largely carried out by voluntsers and Iha trustees are very gratefvl to the many volunteers who carried ¢Jth fvnd raisiThJ on behalf of the TrustthJriTrJ Ihe year. The Trust has, and wiu ccffltir4Je to. sipp(yt th& work of the hospital by flnawog yaiious capital and research proje¢A8 und9rtak?n by I hospital and B¢istol Universty. Flnonrlal activitlg8 and affair¥ The hav8 be8n rKJ th8nge5 in the polioes ofth8 Trust during the #r. During the year inrx)miro resour5 from fundraising, donatKJns artd lega¢iè$ and iftvèsbnent in¢ome lotslbd £315,24612023." £221.487, and expenditura on specific projèus amotsntad to £949,503 12023.. £140,2781. After deducting the chaws operats.ng expenses and allowing for the realised and unrealised investment ievaluation su@u¥os resuttirg d?ficit for the ar was £368.070 12023".surplus 252.1751. At the year end the Twst's balance sheet showed total funds of £4.988,632 12023.. £5,356.7021 of which £4,1,402 12022.. £5,309,814) wère unre8trthY IwKI8. Pag& 2
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE ANNUAL REPORT AND FINANCIAL STATEhlEKrs YE4R ENDED 31 DECEMBER 2024 Reserwei The unresth¢ted ftJThY represents the a¢eurnulated $urpluso3 from previous years. The polKy of Ihe Tnjst is to bu1 these reserves by judiCu5 management ol invèthant assets to maximtse the Éncome available for fvt yea. The eypenditLsre on thariiati objectives each year depends on requests from the h05Prtal management. All expenditu 15 approved by lh• hosprtal management bèlor8 being presèntèd to the Trustees * quartÈrly meehngs Th818v81 of rès8rv8s ss reviewed at the meelngs and decisions regarrting expenditure is made by the Trustees hang gwen considerabon to available reserves and fvrKls already cryllmitted. The Trusteès keep suffiuent rèsaNes to sypport any lorrfJ tsrn commitments to tre hospital. Surplus fgSafv85 hav• b6trn inbested to maximise #)come and )nsequent 4nwd5tm8rts are alIable to be 1g9lised Should charitsb trxpenditum excJ a¥ai18ble cash in bank. The r¢stri¢tod lunds rgpre8gnl hekd tr spè¢i&¢ purposes as set out in note 12 lo the finarK5al statements Tru•tsw' ponsIbIlIty for the accounts Law aFP1Kab to charities in England and Wales requires the trust8es to prepare financsal statements lor each financial year. give a tru¢ and fair vi8w of the finanry81 activit5 of the th8rity during the year aThJ ol its stsie of affairn at end of the year. In prèparing those nancial statements trustees are required to.. 1. Sa16Ct sthiabb a¢¢ounD"ThJ pol1&$ aThJ apply them ¢onsistenty', 2 M8ke judgrnent¥ aTrJ 88tirnate8 that org reason8bb and prudèn(' 3. the methots and prirKiples in ts Charities SORP 4. Statg whether applicable accx)unting standards and ststernents ol récommendsd practts bg•n Ic41rrw8d. subJ8ci to any materral departures diselosed and èxpL4in•d in the financial Statements,. and.. S. Prepare Ihe financial ststsments on th8 going conrn basis unles$ 4t 1$ inappropnats to pr8sumg that the Charity wll Contin in operatJ"on. The trust&s arè r85ponsibk for keeping prLyer 8ecounting records. which disclose wilh reasonable a¢curacy at any b.me the finaneial position of the charity and whith enable them to ensure that the financaal stements compty v47th Sactrt 130 of the chaiib.es Act 2011 and ggneral FJW. They are atso responsib for safeguaiding ass8ts of thè charty and hence for tsking reasonable 5t8P5 for Ihe prevention d d•tethin of fraud and oth6r irrggulariti8s. Rl8k managomgnt The trust895 have assèssed the Major risks to which thè Trust is expod. in particu1 ItKJ5e related to the opelati0t aThJ of the Trusl, aryj are satisfied that systems are in pla to rnate eyposure to suth IBks. InvestThent pollcy The trustees have the Fth%Er to invest in such assets as they See ft. Thè invÈstment o)mmittee meets st least three times È yÈar to féVKaW the investment Fortlolio aThl the cash requirements of the Trust FOT the last few years the Trust's IncMe has exceeded its requiTernents and as a result the investmènt stratagy is to invest in low and medium ii¥k InentS to balance capital appTraation with a reasonabb incomè fiow to •nabl8 the trust to meet its o*ctives. Approv by th• tru8ts08 on 24nd 8lgngd on thelr b•half by: Carnline Ow•n Tru$te• P¥3
INDEPENDENT AUDITOR'8 REPORT TO THE TRUSTEES OF The FRIENDS OF BAISTOL HAEMATOLOGY AND ONCOLOGY CENTRE Optnlon We have audited the finano81 statarn&nts of The Friends of Bristd Haernatology aThJ Oncology Centre lthe'ChanWI for the year ended 31 t)ecèmber 2024 whith cLJmprise the Statement of Financial A¢tivities, B8lan¢e Sheet. Statement of Cash Fk)vrfs and notes to th financial statements. inclurjing a summary ol signifirant accounting pdicie5. The financ1 r8ports.ng tramÈwork that has been applied in their t)repai8t'on is applicab law and United Kj'ngdom Ae¢ounb"ng Stsndards. iUdI Financial Reporting Standard 102.. The Fin8nckl Reportirsg Standard appli¢the in the UK and Republ of IrelaThJ (United K¢ffjdc¥n Geneiamy Ac(wted Accountin9 Pracb'ce}. In our o11nTh, the financAal stat8m8nts'. ' givè o true and fair view of the state of thg Charitys 8lTrair¥ 98 al 31 December 2C¢24 and of ts incx)me and expemdlture for the year then ended., . have been propeTty prepared in aeeor(Janc8 with United 'rJdoM GeneTally ACted AccounlAI9 Prath"ca', • been preparwj ut ?cGwd8n¢e th the wulrements ofthe Cha17t Act 2011. Ba•1• for OpOn We condvcted our audit in aC£ordar with Intemational Standards on Auditing IUKI {ISA8 IUKII and appltcable law. Our responslbllrties under those standards 8re further describpd in the Audrtofs responsibilth.es for the au(Ift of the finanoal statements section of our pOrl ar8 Indyndent of the Charity in accordance wilh th8 OthiL¥I r9quirernents that are reVant to our audit ol the finanaal statements in the UK. induding the FRC'S EthiGg1 Standard, and we have lulfiRed our Dlher elhical Tesponsbilities in acrdn with these requirements. We bdieve that the audrt een we have obtained Is SUent and appropn to promde a basis forour opinn. Concfuslons relatlng to going concern We have nothny to report respect of the floW1ng matters in relth.on to whh the IW {UKI require to report to you where.. . the tnJste6S' of the gOg concem basis ol atcoullting in the preparation ol the fin8ncial statements is not appropriate,. or •the trustees have not dis¢losed in thg finaniaal statements any hlentifred material nrtainlIeS that may cast $wJnifica#t doubt about the Ch2rrtVs 8IrtY to CDntMue to ayopt the going concem ba&s of a¢counling for a period of at least tAve months from the datè when th& financial statements sre 8uthoris8d for issue. Other Informailon The trustees are reSpCs1b forthe other infonnation. The other information comprises th8 infomiats.on Niduded in the 8nnual rèport other than thg financial statements aThJ our auditor's report there. Our opinion on the financial statements does not cover the tsther 1nfomiab.ttn and. exceptto th• txtent othgLWi5g eXplicY stated in our report, we do not &jre$S any fr)mi tsf assurancg conclusion thgreon. In connection wrth our alIt of the financo18¢8t8ments. our ponsIbIlIty Is to thè other infom&titsft and. in doin9 $0. cnnsider whether the othol infofmation Is materialty inconsistent with the ffinaneial $18t8m8Ttts or our knowledge obt&"n&J in the aLpJrt or otherwise appears to be materially misstated. If we Klentify such m8terial inconststsn(ies or apparent mgttsrkgl mssstsl¢ments. we are required to detem)ine whether there ss a material misstatement in thè fin8nc%al statements or a material misstatement of the other infomiation. If. bed on th8 work we hava perforngd. we condude that there is a material misstatement tsl this other information, we are require(1 to report that fa(a. We ha nothing to report in Ihi% regard. hlatsr¥ OTr whlch wg ar• rwulred to rèport by axpIlO In li9ht ol knowledge and understan(Sing of the Ch8rity al its ènvironment cètained in the course of tho audth. not I8ftbfjed materiat rnisstaternents in the Trusteos. Annu ReporL Page 4
We havè nothing to report n respe¢t of th& IloW1n9 mattars in relation to which the Charftth Act 2011 requirgs us to raport to if, in our opInn.. •suffi¢ient accounting récords have not been kep(. . the financial statements are not in agreement with the accounting records and relurns,. or •w¢ have not obtsined all the inforynatson and expL8natsons necessary 191 th¥ purposes of our audiL R•spon81ts11Stlos of the trustee8 As explained mcye fully in the twstees, rewn81M.es Statement set out on page 3, the trustees are re8ponsitAe forthe PTeparation of the financial 5taternerits and foT b6sng satisfied that they give a truè and lair wew. and for such intemal cntrol as deterrnin8 is fwessary to gnable the pr8parab.on ol financial staten)ents that are fr from matsrial mvastatement, whether due to fraud or $rror. In preparing the financ4al ststerngnts, the trustees are responsib fDr assessing the ChanlY$ a"lIty to conts.nue as a going CcMm, disclosing, 8$ apwlicable, matters relaled to 90ing nCeM and using th8 gtsing concèm basis of accountirg unlgss the trustees eith8r interyj to liquidate the Charity or to CA8s8 opèr8tions, or havg no realisl'¢ #emati but to do so. Our respon$5bllJtle8 for thè Audlt of th• financlal statemgnts K•y audlt matt•rs.' our arnnt of rL•k8 of mat•rial ml$$tatsment Key audit malters ?re those rnatters that in professsonal iudgernont were of most signifiC8n in th8 audtt of fInarla¢ 5tatemeftts and indude the most sKJrtthcant assessed T%sks of rrtateri81 misstatement Iwhether or not duo to fraudl entified by us. induding those had the greatest effect on the ollocation ol ro$ourcè$ in the aLKlit. and directing th8 efforts of the engagèmént team. There are no key are&$ identified as the audit lo•J nsk noal awlit woc&Jures a¢lequote in all audrt ale8S. Wg a9d to repDrt to lh8 board of Irustees ary corracj or uncorrected identifEd misstatements Id•ntsfying and rèportlng of rl•k8 of matsri41 miaststemènt due to fr4ud To ¥Jèntify r(sks of material misstatemert due lo fra4KI wtr assessed events or condth.ons that coukl indicate an incènb.vè or pressure to cnmmit fra1 or pro¥ an opportunty to c(vnmit fraud. Our risk ass8ssmant prOdre$ Indud.. li) enquiring of the trustees and inspection ol kny p8peis provided to thw charged with govemanee as to hbJh bvel pollaes and procedures to prevent and detect fraud. lill ravièwin9 the minutes of trustees, maatings. We rMmunICated id9ntified fraud risks thiougttout the audst team and rgmalnad alert to any indir2tths offraul through)ut thg 8wth't. As iequired by Audrts'ng Standards. and tsking into a¢o)unt our overall ol thg control virOnmert we perfomed procedures to assegs the rssks of rnanagement ovorrida of c1)ntlS. To address thè paJvasNe risk as it re18tad to management override ol ¢gntrols, we raviowed matérial journal •ntMs and 89re8d thèsè to supporting docvmentslion Whe appropriate. 1dontn9 and r•#pondlng to rlsks of mat•rfal rn18ststsm•nt du• to nonrfompliance with la and regulations Vva Klentifred areas of law5 arKJ WulanS that cky r8230nabty be expec*d to ha a materfal èffect on Ihe finan¢i818tatements from our general commercial and sectw ex[nc& and through discu$$ton with tt)e Treaswer. As the charity is tsgulat8d, our assessrngnt of risks inwlvs(I gainir¥J an U1[StaJ1n of the n1rd eft¥ironm&nt includir4J the enbtys Pfocedures for complyng wth regulatory reqUIrnents. Page 5
We communicated identifd lawts and r8gul?tions throughout our tsam and remainéd art to any IndiOn$ of non-Q)mplkanc throughout thè 8udrt. Audn9 Stsndards limit tha rUIred audit PT[edureS to tdentfy non-compliance with these law5 and regulations to enouiry of management and trustees and inspection of regulatory and bgal ¢orrespondence. if any. Therefore, rf any breath of 0rational regulati i8 not disdosed to US Of evYJent from relevant corre5pon¢jan, an audrtwll not det6Ct that breach. Limitstlon8 to th• ability of tha audlt to dele¢t fraud or Ix8ach8$ of Ipw$ and gulatIOn Owing to the inherent Imitaon of an audrt, thère an unavoidable risk that w may not h8V8 detected some material mtsstat•ments in financial statemonts, tIKJugh we have properly planned and pgrfomed our audit in accordan audrting standards For exarnph, thé furthèr removed non-compliancg with law5 and regulations i8 from the events aThJ trans8d10t reflecthd in the financial st81nts. the less likety the inherentty limited prOdre$ raquirsd by AtKlthg Standards would tdgntrfy rt. In 8dditii)n. 83 with any a1&1, thérè rémained a h%Jher risk of non4trtectitsn of fr8Ltd, 85 this rnay involve collLTrSiOn, forgory. irtentiDnal omissions, mYsr&presentats"ons, or the overrKl8 of internal controls. Our aLMJst produreS are dÈsisned to detect material misststemen( and therefore we are not rB5ponsible for F¥eventng non-compliance or frgud al onnot tr expected to detect Tron-compliance wth 811 law3 and regul3tions. A further descriptith of our iesponsitilities tcthe aLKlitof the financial statements is located on the Financial Reporting Counc4's websit6 at ww.Irc.org.ukloudrtorsr95Fonsiblits'e& This descripti lomi$ part of our 8udrt¢rfs report. UB? of our report Teport is made soklyto the ChgriW$ trustee5, as a body. in acCon kmth seditsn 144 ofthe Charities Acl 2011 and th• ragUlatn5 made undar section 154 of Ihat Act. Our audit worf( has undertaken so that we rnight state to the ChariV$ trustses ihose matters we are required to Stale tts them in an auditorfs report and for no oth81 PUtP058. To the luljest extent permitted by I, we do not accept OT assume responsibility tr& anyone other than the Charitys trustses as a b(xly, for our audit work, for this raport, or for thè optnions we have Paul Crrdland Chsrlttsn Baker (Bristo4 Ltrj ICharter8d Acwuntsnts and Statutory Auditorl 1 Flwr, 61 Macrae Rcd Edgn 8wine5s Park Harn Green Bristol BS20 ODD 25 P890 6
THE FRIENDS OF BRISTOL HAEMATOLOGY ANO ONCOLOGY CENTRE STATEhlENT OF FINANCIAL ACTIVITIES YEAR ENDED 31 DECEMBER 2024 2024 Restrict•d funds 2023 Unrgotrlcted R08trfctod lund funds Unrè8trl¢ted fund Totsl Totsl Note Income #nd èndowinants Don8ts"ons a1 xies Other tr&Jbng actmties Investment income 143,052 44,852 108.521 18,564 161,616 44,852 108.778 83.111 26,718 109,829 2.836 108,822 2,836 108,537 257 285 Total 29S,425 18.621 315,246 194,484 27,003 221,487 ExpendthJFe on Raising funds charitab actiit 20,OS5 98.112 20.035 999,372 2,283 184,070 901,280 86,S56 97,514 Total 118.147 1,260 1,019,407 86,819 97,514 186,333 Net incom• 178,278 1882,4391 1704,161} 105,665 170,5111 35.154 Transfars Gross transfers baen ftjnds Net in¢omo t6fore other r•cogntsed gains and 108898 ie62,7811 8e2,781 167.2691 67,2e8 ie84,$031 119,6581 1704,1611 38.397 13,2431 35,154 OTHER RECOGNISED GAWS (Lossèsllgèins on investrneftts Realrsed gasns on dy)0s81s 60.804 83,313 83,313 Unrealised gain8lllossg51 on r&valuth"ons 275,287 275,287 133,708 133.708 Net mo¥wn•nt In fund 1348,4121 {19,6581 {368,070) 255,418 13,2431 252.175 Total fund¥ broughtfor*ard 5.309.814 46,888 5,356.702 S,054,396 50,131 5,104,527 Totsl fundè eattl•d lorwanl 4,961.402 27,230 4.988.632 5,309,814 46.888 5,356,702 All actNf(ies relate to Cx)nlnuing 0ratiOnS. I galns and losses recognised in the ar are included in Ihe Statement ol Financial A¢tMtitrs. Pag6 7
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE BALANCE SHEET YEAR ENDED 31 DECEMBER 2024 2024 2023 FIXED ASSErs Inv8slments 4,889,241 4,603,040 CURRENT ASSETS t)ebtors Cash at bank and ift hand 10 75.000 43.480 118.480 1.549 759,641 761,190 CREDITORS: amounts falllng dug wlthln on• 11 19.089 7,528 Net C#JKrent assets 99,391 753,f62 Total assets less curront Ilabllltl&s 4.988,632 5.356,702 Funds Unrestrici6d luTh 12 4.1.402 27,230 5,309,814 RtrIcted fund 4.988,632 5,956.702 Approved athorised for Yasue by the Trusl8e8 on $141 q• ¢3 and $NJrwJ on Ittr b&half by Mrs O GrogoTh)- Chair OG The notes on pages 10 to 15 fomi an integral part Of189 accounts. Pgge 8
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE STATEMENT OF CASH FLOW YEAR ENDED 31 DECEM8ER 2024 Total Funds 2024 Totsl Funds 2023 Noté Ngt ¢4oh 9onratod by operating acti¥ltl•# 15 1874,8291 146,8691 Cash frcm7 investing actiVe$ Intgrost and IendS Tr&n5fgr from stockbrc&9r 108,778 49,889 108.822 25,683 Caah providgd by invè¥ting a¢tlvilia# 158,867 134,505 Chany In Cash and cash 0qulvants In th•y•ar (716.162) 87,636 Cash and (ash equNaknts brought forward 759,841 672.(X)S Cash and fAsh •qui¥alents ¢arrfed fovard 43,479 759,641 Pag8 9
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINAlAL STATEMENTS FOR THE YLAR ENDED 31 DECEMBER 2024 Accountin9 pollcl•s Basis ofprepaiation 8nd assessment of going conr The finanaal statements have b¢on prepared under tho histofical cost convÈnb"on, 8$ modhfjed by the reVaallOn of c¥rtain ftxed assets, and in acco¥dancè with the Staterngnt of Recommndsd Practi 'Accounts"ng and Repoth"ng ty Ch8rllTes pr0p3ring their accounts in acrdanCe with Fft)ancial Reporting Standard applicaue in the LIK and Republi¢ gf Iretand, {FRS1021. applicabk accounting $tsndards WKI the Charities Act 2011. Th• Trust thnstitutes a public trrt 8ntity as defined by FRS102. Incomlng re80UfC•S Donations are a¢rx)untecl for when re1Ve by the Trust and legacies are rety)gnised wh8n it is pYd)atrAe that they vll te receNed. Oth income 15 accounte(I for on ¥n accruaL8 basis as lar as rt is prudènt to do 80. Incnm$ ILJe3 income tsx recovwabje. R88ources expended LBbilibes are recogni58d as soon as thore is a legal or construth.ve obligation ¢ornmtiti'ng the charity to thg expenditurè. I1 ayndit• is a¢counted for on an accnsals basis ar]d has been ¢J8ssthed under headings that 8gJre9ate all costs related to the caiegory. ChaTitabkg eXpenortu ¢omprise3 thw costs incurred by the charity in the delNery of rts aL¥J"Wt$ arny seNKes lor its beniarEs. It incltsdes both costs that can b& directy altocated to thg activity and indirect Costs required to support the )rk of the chwity. Gifto In klnd The Trust reco15 tha beneff( of work ¢arried out by voluntsgrs and ts all¢xated a room al the Cgntre free of charge, No value is placed on these iteffls. Taxation As a registered charity, the trust is exempt Ironi tax as it has no tsxable 8CtivitEs. ITrable VAT borrÉ by thg Tru$l 1$ Indu in the cost of Ihg rtem to whth it relates. Invents Investment inwmo IS taken into a(xount on the basL% of the due date tsf paymtnt. Invgstments are a fomi of basic financ¥al instrLMnent and are inthally rwnised * their trarr&acbon value and subseqvenuy measured at t1r fair va$ as at the balance Sheet date using the cl¢sing quolecs market All gains and105ses, thether r8alised or unraalis8d are credited or charged to the Unrestricted Fund. Fund ¥OUnt19 Unrgstiict&J in(¥me ndS are g¢neral fu1$ that are avaikble for use at Tru9t, discretion in fvrtheran of the ci)iectNes of the charrty. Restricted funds are thos8 donated for use in a partiujlar aroa or fora 5peufic purpose, Ihe use olwhth b rests¥Xed to that area. Detsils olthe nature and purposÈ of each fiJTrl is set oui in note 12. Governance ¢OBts Govemanrg costs incjude costs of the preparation and examinalK)n of the Report aTrJ Flnanci81 StstEmgrt ¢o¥ts rdating to Tr. meebngs and any legal costs relatiro to governan and constitutional mattgrs. TranstionS wlth Tru8tee8 and oth•r eonn•¢ted pernon8 No transacInS took place tren the Trust and th• Trustees any Fer50ns conned *ilh tkn. Pag9 10
THE FRIENDS OF BRISTOL HAEl•lATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEM8ER 2024 Donaliom and legacig¥ 2024 Restricted fund 2023 Unr••trl¢ted RtrICtd fund lund Unr•strt¢ted fvnd Total Total Donations Tax Tthnds 60.534 7.518 75,000 18,564 79.098 7.518 75,C(rf) 71.091 26.718 97.809 12.020 12,020 143,052 18,564 161,616 83,111 26,718 109.829 4. Othw ¢tMl•8 to g•nerate lund8 2024 R•strlcted fund 2023 Re8trictod fvnd Unrgstrietèd fund Unréstrlct•d fund Tot•1 Totsl sa of merchandise 1.275 43.S77 1,275 43,577 2.836 Events Nn by the trust 44.852 44,852 2,836 2,836 & Inv•¥lm•nt ine¢)m• 2024 R•8tricted lund 2023 R•strlct•d fund lJnrèstri¢tofl fund Unre8trfctsd fund Toi•l Totsl OivKleNJ$ from UK l%%ted investrnents Interest receivable 98.972 9,549 98,972 g.8r 97.415 11,122 97,415 11,407 257 285 108,S21 257 108,778 108,537 2&5 108,822 6. Rai8ing Fund8 2024 Unregtrlcted RgStri¢tsd fund nd 2023 Rèstrlctèd fund Unfestrlcted fund Total Total Purchasè ol itams foi sale Cost of evgnts lun by Ihe TftKst 2,263 19,049 19,049 20,03S 20,035 2,263 2,263 P•3&11
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CEKfRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 7. Dgtalls of Charftatsl• Actlvltl•s 2024 Rèstrletèd fund 20ZJ Rtrictfjd fund Unrt8tAet¢d fund Unr•8trlet•d fund Totsl Totsi rants and Donatlon8 Equipmènt purchase Rgsearch $4laries Patient thefapy Pthnt amensbes Paknt granls Course5 trdining library Support Costs Insurance 821,832 77.758 821,632 93,371 18,000 5,405 1,870 9,225 91,427 91,427 14,80S 14,450 6,480 5,447 7,668 15,613 18,(KM) 5,405 14,8C6 14,450 5.840 640 5,447 1,B70 9.225 1,065 9,619 25,871 2,169 Em(Aum8nts of emplo Stod(brok8f s fees Soc4al media offi cnst G0mne• costs 11,C69 27,097 4.230 1,779 17,069 27,097 4,230 1,779 9,619 25,871 2.169 Audltofs remun¢r*Éon 5,070 5,070 98.112 901,260 999,372 86.556 97.514 184.070 8. Stsff Stsff costs were as folbws.. 2024 2023 Charga for salaries from Universty Hosytsls Bristol NHS Foundation Trust 11,¢ 9.619 Thgro was employee througl¥)ul the year. Th¢s wrployee not rlY? gmolumgnts ofmore thon £60,CNJI. No trustees have reIVed any remuneration or 1MbUrSed eyens¢s during th& 81. nor any thjsteè have 8 disdosable interest in any of thè eharitls transaetions. pa 12
THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE NOTES TO THE FINANCIIL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 9. Flx8d a8s•t in¥•stmont* 2024 2023 UBted Inv••knents at rnark•t value O¥erse¥s Equity Shares UK Equity shares P0erty Trust Altgm8tW85 FiKgd intsrest bonds 2,516,423 932,414 47,700 197.100 889,458 4,583.095 306.146 1.741,2eO 1.841.861 96.705 198.164 912.982 4,590.772 12.268 4.603,040 Cagh 4.889.241 H8torleAI cost ol Itsted Investments 4,051.271 4,334,236 Llgtsd Invtrents Cash Totsl Markét Value.. At 31 Drnber 2023 Add"onS Disposals lnuease in value in year Transfer to Incoma 4,59).772 1,619.242 11,902,2C61 275,287 12,268 1,963,009 (1.619,2421 4,603,040 3,582.251 13,521.4481 27S.287 149.8891 149,8891 At 31 Oettmb8r2024 4,583,095 306,146 4,889,241 At 31 Dèixnbèr 2024 thèré werè hvo holJitvJs with a market valu8 in 6X$S of 5% 01 the total value A httlling ol S&P I shares had a market value of £512,213 and a hokying of Vanguard FTSE Developed Worfd hwl a markat value of£498,474. 10. D•btor¥ 2024 2023 Prepaid exp&ws LgJacAes due 1,549 75,1XJO 75.000 1,549 11. Cr•ditorn: amounts falling du• wlthln one year 2024 2023 Acuued expenses Unpwd involS 4.800 14,289 4,500 3.028 19.089 7,528 Page 13
THE FRIENDS OF BRISTOL HAEhlATOLOGY AND ONCOLOGY CEpifRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 12. Fund$ At31 Decèmb•r 2023 TrdnsfBrs b•lw8en funds A131 Decembgr 2024 Incorning Resourc•s expended Ro8lrlctsd Fund8 Equipment fund- to purchase and maintsin medical equipment Research Fund- to fvftil rèsearth projects Mat5dgn beque31- to fjjnd research s8krias Earrnarted fund- gilts for other puwe5 13,982 238 821,631 77.758 807,649 55.132 22,388 1,485 23.015 46.888 19 1,504 25,726 27,230 4,582 18,821 1,871 901.260 862,781 Unrestii¢tod fund$ General fvnd 5,309.814 S,356,702 632.516 651,337 118.147 1,019,407 1862,7811 4.961,402 4,988,632 13. Analysis of ngt betwMn funds Unrestiicted Funds Restricted Fu$ Totèl Funds 2024 Investhients culnt ass&ts 4,889,241 91,250 119.0891 4,961,402 4,889,241 118,480 119,0891 4,988.632 27.230 Credrtors due %4Athin one wr 27,230 14. Approved futur• fundlng AE 31 D8(8mbfyr 2024 the trust had entered into the fomowing fwidw c(nrnitrnenls. Coursos for hosprtal staff Infom)ats"on support and research salarS TYA rDmplimentary therapies Prgctib'oner for CART 11 therapy Auto outlining sofNvara Brachytherapy HDR Bariatic trolley ECG Picc Equipment Pi¢c rocKn char Steev Phantom Wheelchaits 16,() 26,000 40,0 89,300 53.874 318,000 25.000 10,400 5.950 31,233 1.600 Psgè 14
THE FRIENDS OF BRISTOL HAEMATOLOGY ANO ONCOLOGY CENTRE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 16. Re¢on¢lllatlon of n•t rnowment In fund8 to ¢a$h Ilow trom operatlng actlvltltts 2024 2023 Net movement In funds Less investment incorne 1368,0701 1108,778> 1338.0911 (73,451> 11,561 252.175 1108,8221 1217.0211 28.451 11,6521 Less losslgains on investrnents DeaSe111ncre8seI in debtors {Detrtras*yincrease in crediiors Nèt cash gtrner8ted by operating aciiwiti8S 1874.8291 146,8691 P¥15